1d:I[2890,["266","static/chunks/870fdd6f-4fcc92c129a57d11.js","970","static/chunks/970-91a3a37cc668faba.js","857","static/chunks/857-3b2a1421afa266d2.js","965","static/chunks/app/podcasts/episode/%5BpodcastEpisodeGuid%5D/page-e939c6b91b4a25d4.js"],"default"] 1e:I[1318,["266","static/chunks/870fdd6f-4fcc92c129a57d11.js","970","static/chunks/970-91a3a37cc668faba.js","857","static/chunks/857-3b2a1421afa266d2.js","965","static/chunks/app/podcasts/episode/%5BpodcastEpisodeGuid%5D/page-e939c6b91b4a25d4.js"],"default"] 1f:T787,

In 2022, WHO’s African Region saw 233 million cases of malaria, with 580,000 deaths. 80% of those deaths are children under 5. The phase 3 trial of the new R21/Matrix-M malaria vaccine was published in The Lancet this month, and the results suggest a turning point in the fight against malaria. Gavin is joined by Professor Sir Adrian Hill, one of the creators of the vaccine, to discuss the process the vaccine went through, the history of malaria vaccine research, and what the future holds.

Read the phase 3 trial here:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02511-4/fulltext?dgcid=buzzsprout_tlv_podcast_generic_lancet

Read all of our content at https://www.thelancet.com/?dgcid=buzzsprout_tlv_podcast_generic_lancet

Check out all the podcasts from The Lancet Group:
https://www.thelancet.com/multimedia/podcasts?dgcid=buzzsprout_tlv_podcast_generic_lancet

Continue this conversation on social!
Follow us today at...
https://twitter.

‌

Episode description

A new vaccine in the fight against malaria

Episode description